| Study title |
Alpine-4: Evaluation of Efficacy, Safety and Tolerability of NGM282 (Aldafermin) in a Phase 2b, Randomized, Double-blind, Placebo-controlled, Multi-center Study in Subjects with Compensated Cirrhosis Due to NASH |
| Disease or condition |
NAFLD/NASH with Fibrosis and Cirrhosis |
| Study type |
Interventional (Clinical Trial) |
| Intervention/treatment |
NGN282 (Aldafermin) or Placebo |
| Phase |
2b |
| Study site |
Duke University |
| Study location |
Durham, NC |
| Principal investigator |
Manal Abdelmalek, MD; manal.abdelmalek@duke.edu |
| Study coordinator |
Lauren Roberson; lauren.roberson@duke.edu |
| Phone contact |
(919) 681-9591 |
| Clinicaltrials.gov link |
https://clinicaltrials.gov/ct2/show/NCT04210245 |
